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Development of dairy beverages functionalized
with pure ergosterol and mycosterol extracts: an
alternative to phytosterol-based beverages†
Sandrina A. Heleno,a,b Adenilson R. Rudke,a,b Ricardo C. Calhelha,a
Márcio Carocho,a,b Lillian Barros,a,b Odinei H. Gonçalves,c Maria Filomena Barreirob
and Isabel C. F. R. Ferreira*a
In the present work, Agaricus bisporus extracts obtained by ultrasound-assisted extraction (UAE), and
ergosterol, were incorporated into dairy beverages at concentrations mimicking commercial phytosterol-
added yogurts, to work as alternatives. The samples were analysed for nutritional and bioactive properties,
and compared with controls (yogurts with no additives or phytosterols), at two storage times (right after
incorporation (ST = 0) and after seven days at 4 °C (ST = 7)). The ones incorporated with the extract (YAb)
and with ergosterol at the same concentration as in the extract (YPEAb) showed similar antioxidant pro-
perties as the ones with phytosterols (YPhy), but a higher cytotoxicity against tumor cells. YPEPhy, the
sample with ergosterol at the same amount as phytosterols in YPhy, was the strongest in both bioactiv-
ities. For YAb, YPEAb and YPEPhy the antioxidant capacity increased from ST = 0 to ST = 7, meaning that
the extract and ergosterol protected the yogurt from oxidation, improving the shelf life. Nutritional para-
meters were identical for all samples.
1. Introduction
The market for functional foods is evolving very fast, its
growth estimated as being 10% per year. In this business
segment, the fastest growing sector is the one of functional
beverages (functional drinks)1 which grew 2.5%, between 2008
and 2011, in Latin America.2 Also in this context, functional
dairy products in Germany had an impressive increment from
5 million dollars in 1995 to over $300 million in 2000.3
Dairy beverages containing phytosterols, which are mole-
cules claimed to be able to decrease cholesterol levels,4 can be
currently found at the commercial level. In fact, the consump-
tion of standardized levels of sterols is recommended by both
European and US guidelines. Besides plants, these molecules
also exist in macrofungi, in this case designated as myco-
sterols, ergosterol being the most abundant sterol in Agaricus
bisporus (J. E. Lange) Imbach.5,6
A. bisporus is the most cultivated and consumed mushroom
worldwide, with an output of 4 million tons in 2009.7 This
high production and consumption can be explained not only
by its pleasant taste, but also by its biological properties, such
as antioxidant,8,9 antimicrobial,8,10 anti-inflammatory,11,12 and
antitumor13 properties among others. These bioactivities are
related to bioactive molecules such as phenolic compounds
and tocopherols,10,12 but also to ergosterol that represents
approximately 90% of its sterol fraction.5,14,15 In addition,
ergosterol is reported as having interesting hypocholesterole-
mic activity, acting like phytosterols.16,19
The mushroom industry generates large quantities of by-
products17 whose amount can vary between 20 and 35% in
weight of fresh mushrooms.18,19 These residues can proceed
from cultivation and harvest, where specimens with irregular
dimensions and shape are discarded, but can also include
other by-products such as the volva and bottom part of the
stems due to their tough texture. They usually have no valued
destination, being used for low-economic solutions such as
animal feed and compost. Alternatively, these by-products can
be proposed to extract ergosterol thus obtaining a high added
value molecule for various industrial applications (100 g of the
product with 98% of purity can cost about $800).
In the present work, mycosterol enriched extracts were pre-
pared from A. bisporus bio residues by ultrasound-assisted
extraction (UAE). These extracts, as well as pure ergosterol, were
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incorporated into dairy beverages at concentrations reproducing
commercial phytosterol-added counterparts. The achieved
diﬀerences and advantages were discussed aiming at highlight-
ing the competitive role of mycosterols towards phytosterols.
2. Materials and method
2.1. Samples
Agaricus bisporus L. bio residues (volva and the bottom part of
the stem, specimens with irregular dimensions) were obtained
from a local mushroom production enterprise “Mogaricus
Cogumelos – Sociedade Unipessoal Lda”. The samples were
weighed, lyophilized (FreeZone 4.5 model 7750031, Labconco,
Kansas City, MO, USA) and reduced to a fine dried powder
(20 mesh) for subsequent assays.
The base yogurts for the dairy beverages’ preparation were
purchased from a local supermarket. They were composed of
partly skimmed milk, sugar, glucose–fructose syrup, lactose,
milk proteins, strawberry pulp (1.4%, w/w), modified corn
starch, flavorings, lactic ferments, a preserver (E202) and a dye
(E120). The nutritional declaration per 100 g includes: energy:
72 kcal; lipids: 1.1 g corresponding to 0.7 g of saturated fatty
acids; carbohydrates: 13 g corresponding to sugars; proteins:
2.3 g and salt: 0.13 g. Commercial yogurts with phytosterols
include in their composition light milk, esters of plant sterols
(3.4%, w/w) that correspond to 2% of free plant sterols, straw-
berry pulp (2.5%, w/w), lactose and milk proteins, modified
corn starch, flavorings, lactic ferments, sweeteners (E955,
E950), a preserver (E202) and a dye (E120), with the following
nutritional declaration per 100 g: energy: 41 kcal; lipids: 1.4 g
corresponding to 0.1 g of saturated fatty acids; carbohydrates:
4.2 g corresponding to 4.0 g of sugars; proteins: 3.0 g and salt:
0.13 g. For energy purposes, the 2 g from the plant sterols were
excluded since they do not contribute to the energetic value.
Both yogurts had a shelf life of 21 days. The used solution, in
terms of the chosen base yogurts and yogurts added with
phytosterols, was the most suitable face for the existing market
options. In fact, no natural yogurts incorporated with phyto-
sterols were found, which is the reason why the strawberry
flavored ones were used, to guarantee as much similarity as
possible among the samples.
2.2. Standards and reagents
Methanol and acetonitrile of HPLC grade, and chloroform and
ethanol of analytical grade were acquired from Fisher
Scientific (Lisbon, Portugal). Trolox (6-hydroxy-2,5,7,8-tetra-
methylchroman-2-carboxylic acid), the sterol standards: ergo-
sterol (98%) and cholecalciferol (98%) were purchased from
Sigma (St Louis, MO, USA), as well as, as also acetic acid, phos-
phate buﬀered saline (PBS), sulforhodamine B (SRB), trypan
blue, trichloroacetic acid (TCA) and tris-(hydroxymethyl)ami-
nomethane (TRIS). Dulbecco’s Modified Eagle’s Medium
(DMEM) and RPMI-1640 medium, fetal bovine serum (FBS),
Hank’s balanced salt solution (HBSS), L-glutamine, nonessen-
tial amino acid solution (2 mM), penicillin/streptomycin solu-
tion (100 U mL−1 and 100 mg mL−1, respectively), and trypsin-
EDTA (ethylenediaminetetraacetic acid) were from Hyclone
(Logan, UT, USA). Water was treated in a Milli-Q water purifi-
cation system (TGI Pure Water Systems, Greenville, SC, USA)
before use. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained
from Alfa Aesar (Ward Hill, MA, USA). All other chemicals and
solvents were of analytical grade and purchased from common
suppliers.
2.3. Preparation of the dairy beverages
2.3.1. Mycosterol extract production. Ultrasound-assisted
extraction (UAE) was carried out using an ultrasonic device
(QSonica sonicators, model CL-334, Newtown, CT, USA), com-
prising an ultrasound probe working in the range of 100 to
500 W at 20 kHz and equipped with a digital timer. Extractions
were carried out according to Heleno et al.20 Briefly, the lyophi-
lized powdered mushroom samples (3 g) were extracted with
100 mL of ethanol using previously optimized conditions
(15 min, 375 w). Before each extraction, an adequate volume of
cholecalciferol (internal standard) was added. After extraction,
the extract solution was filtered through a Whatman no. 4
paper and the solvent evaporated under reduced pressure to
obtain the mycosterol extracts.
2.3.2. Monitoring ergosterol in the mycosterol extracts.
The obtained mycosterol extract was dissolved in methanol at
10 mg mL−1 and filtered through a 0.2 μm nylon filter for ergo-
sterol quantification by HPLC-UV analysis. Ergosterol quantifi-
cation was carried out according to Barreira et al.5 using an
HPLC equipment coupled with an UV detector. The equipment
consisted of an integrated system with a pump (Knauer,
Smartline system 1000, Berlin, Germany), a degasser system
(Smartline manager 5000), an auto-sampler (AS-2057 Jasco,
Easton, MD) and a UV detector (Knauer Smartline 2500).
Chromatographic separation was achieved with a Inertsil 100A
ODS-3 reversed-phase column (4.6 × 150 mm, 5 µm, BGB
Analytik AG, Boeckten, Switzerland) operating at 35 °C (7971R
Grace oven). The mobile phase was acetonitrile/methanol
(70 : 30, v/v) at a flow rate of 1 mL min−1, the injection volume
was 20 μL and the detection was performed at 280 nm.
Ergosterol was quantified based on a calibration curve obtained
from a commercial standard using the internal standard
method with cholecalciferol as the internal standard. Data were
analyzed using Clarity 2.4 Software (DataApex).
2.3.3. Incorporation of dairy beverages with mycosterol
extracts or pure ergosterol. The dairy beverages (100 g each)
were prepared as follows: FY (base yogurt with no additives),
YPhy (commercial yogurt containing phytosterols (2 g)), YAb
(yogurt incorporated with 2 g of A. bisporus mycosterol solid
extract, i.e. mimicking the used quantity of phytosterols in
commercial yogurts), YPEAb (yogurt incorporated with 75 mg
of pure ergosterol, i.e. representing the ergosterol amount
present in the 2 g of the mycosterol extract) and YPEPhy
(yogurt incorporated with 2 g of pure ergosterol, i.e. mimicking
the used quantity of phytosterols in commercial yogurts). The
samples FY and YPhy were used as control samples. Yogurts
were prepared in duplicate and further analyzed at two
Paper Food & Function
104 | Food Funct., 2017, 8, 103–110 This journal is © The Royal Society of Chemistry 2017
Pu
bl
ish
ed
 o
n 
13
 D
ec
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
8/
04
/2
01
8 
14
:0
1:
03
. 
View Article Online
diﬀerent Storage Times (ST): immediately after production
(ST = 0), and after 7 days of storage at 4 °C (ST = 7). All
samples were lyophilized before analysis.
2.4. Nutritional value of the developed dairy beverages
2.4.1. Macronutrients and energetic value. Moisture, pro-
teins, fat, carbohydrates and ash were determined using the
AOAC procedures21 and according to the procedures described
by Souza et al.22 Energy was calculated using eqn (1) (mass in
grams) according to the European Parliament and Council
Regulation No. 1169.
EnergyðkcalÞ ¼ 4ðmprotein þmcarbohydrateÞ þ 9gfat ð1Þ
2.4.2. Soluble sugars. Soluble sugars were determined by
High Performance Liquid Chromatography (HPLC, Knauer,
Smartline system 1000) coupled with a refractive index detector
(RI detector, Knauer Smartline 2300) according to the pro-
cedures of Heleno et al.23 and Souza et al.22 Quantification was
based on calibration curves obtained for individual sugars by
the internal standard method (IS, raﬃnose). Data were ana-
lyzed using Clarity 2.4 Software (DataApex). Results were
expressed in g per 100 g of dry weight.
2.4.3. Fatty acids. Fatty acids were determined after trans-
esterification according to the procedure described previously
by the authors Heleno et al.23 and Souza et al.22 by gas chrom-
atography (DANI 1000) with a flame ionization detector
(GC-FID). Fatty acid identification was done by comparison
with the relative retention times of FAME (Fatty Acid Methyl
Esters) peaks obtained from standards. Results were recorded
and processed using CSW 1.7 software (DataApex 1.7) and
expressed in relative percentages of each fatty acid.
2.5. Bioactive properties of the developed dairy beverages
2.5.1. DPPH radical scavenging activity. The mycosterol
extract was dissolved in methanol at 50 mg mL−1; ergosterol
was dissolved in chloroform at 1 mg mL−1; and yogurt was dis-
solved in a mixture of methanol : chloroform (50 : 50, v/v) at
200 mg mL−1. Successive dilutions were thereafter prepared
from these stock solutions.
The used methodology was carried out according to Heleno
et al.24 The reaction mixture consisted of the sample solutions
with diﬀerent concentrations (30 μL) and a methanolic solu-
tion (270 μL) containing DPPH radicals (6 × 10−5 mol L−1). The
mixture was left to stand for 30 min in the dark, and the
absorption was measured at 515 nm (ELX800 Microplate
Reader, Bio-Tek, Winooski, VT, USA). The radical scavenging
activity (RSA) was calculated as a percentage of DPPH discolora-
tion using eqn (2), where AS is the absorbance of the solution
containing the sample, and ADPPH is the absorbance of the
DPPH solution. Trolox was used as a positive control.
RSAð%Þ ¼ ½ðADPPH ASÞ
ADPPH
 100 ð2Þ
2.5.2. Cytotoxic properties. The mycosterol extract was dis-
solved in water at 8 mg mL−1; ergosterol was dissolved in
DMSO at 40 mM; and yogurt was dissolved in DMSO/water
(1 : 1) at 8 mg mL−1. Successive dilutions were thereafter pre-
pared from these stock solutions.
MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell
lung carcinoma), HeLa (cervical carcinoma) and HepG2
(hepatocellular carcinoma) from DSMZ (Leibniz-Institut
DSMZ—Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH) were used as human tumor cell lines. To
assess the cytotoxicity of the samples, the sulforhodamine B
assay was performed according to a procedure previously
described by the authors Abreu et al.25
For toxicity evaluation toward liver cells, a primary cell
culture was prepared according to a procedure previously
established by Abreu et al.25 These cells (PLP2) were treated for
48 h with the diﬀerent sample solutions and the SRB assay
was followed.22
The results were expressed in GI50 values (concentrations
that inhibited 50% of the net cell growth). Ellipticine was used
as a positive control.
2.6. Statistical analysis
The incorporations were performed in duplicate and all ana-
lyses were carried out in triplicate. Throughout the manu-
script, all data are expressed as the mean ± standard deviation
or mean ± amplitude, when stated. In order to allow a better
interpretation of the results, analyses of variance (ANOVA) with
type III sums of squares were performed using the SPSS soft-
ware, version 23. Relying on a multivariate general linear
model, the dependent variables were analyzed though a 2-way
ANOVA with 2 independent variables. Storage Time (ST) com-
prised the values 0 and 7 days, and Incorporation Type (IT)
comprised FY, YPhy, YAb, YPEAb and YPEPhy, and their mean-
ings are previously described in section 2.3.3. When, in each
assay, a significant interaction was detected for both factors
(ST × IT) meaning that the changes among the samples were
influenced by both factors, they were evaluated simul-
taneously, and general tendencies were drawn from the
Estimated Marginal Means (EMM). Inversely, if no statistical
interaction was detected, the means were compared by a
Student’s T test (for ST) or a Tukey’s multiple comparison test
(for IT), relying on a previous Levene’s test for the equality of
variances. All tests were performed at a 5% significance level.
3. Results and discussion
In order to determine the viability of using A. bisporus as a
source of mycosterols to be used as functional additives in
food products, a detailed analysis of the developed dairy
beverages was carried out in terms of the nutritional profile,
soluble sugars, fatty acids, antioxidant and cytotoxic activities.
In all the tables, ST is presented as a mean accounting with all
incorporation types, and IT as a mean accounting with both
storage times. With this approach, the contribution of each
factor, ST and IT, can be interpreted independently. Thus, the
amplitude reflects values obtained under diﬀerent conditions
Food & Function Paper
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(variations of the non-fixed factor: ST or IT). If a significant
interaction was detected between both factors (ST × IT <0.05),
no multiple comparisons could be performed, meaning that
both factors contributed to the observed changes in the
results, so no specific conclusions can be drawn, and there-
fore, general conclusions were obtained from the estimated
marginal means (EMM). The A. bisporus content in ergosterol
is shown in Table 1 as the 36.72 ± 0.01 mg g−1 extract, in agree-
ment with previous reports that described this mushroom as
the richest one in ergosterol.5,20
3.1. Evaluation of the ergosterol content in the prepared
dairy beverages
All the yogurts incorporated with the A. bisporus extract, as well
as with pure ergosterol, were evaluated in terms of ergosterol
content by HPLC-UV to confirm its presence right after prepa-
ration (ST = 0) and after seven days (ST = 7). As it can be seen
from Table 1, the incorporated amounts were confirmed in the
respective samples, with proximate values for ST = 0 and ST =
7, meaning that ergosterol remains stable in the analyzed food
matrix (yogurt) after seven days under storage at 4 °C.
3.2. Analysis of nutritional profile and energy
Table 2 represents the nutritional profile and energy values for
the evaluated yogurt samples. Moisture was the parameter
with the highest value, as expected for yogurts. Nutritionally,
total carbohydrates followed by proteins were the most abun-
dant macronutrients. The nutritional profile, in terms of fatty
acids and soluble sugars, achieved for the yogurts with phyto-
sterols (YPhy) diﬀered from the other ones, which can be justi-
fied due to the use of a diﬀerent brand. For instance, this
sample had less carbohydrates and lower energy. For all the
performed assays, the interaction between factors ST and IT
was significant, so general conclusions were drawn from the
EMM. In terms of the moisture content, IT had a higher influ-
ence than ST, although no significant diﬀerences could be
achieved. Based on the EMM, the yogurts incorporated with
the A. bisporus extract (YAb), and the commercial ones
enriched with phytosterols (YPhy), showed fat preservation
over the storage time, which indicates the antioxidant activity
of this mushroom extract (ESI 1A†), similar to the one of phy-
tosterols. Furthermore, A. bisporus seemed to have preserved
the protein fraction (data not shown), which is quite desirable,
given that protein destruction in foodstuﬀs is usually related
to oﬀ flavors. Overall, the nutritional profile of the yogurts was
not significantly modified by any type of incorporation, and
given that the yogurts were kept at an adequate storage temp-
erature, few changes were actually expected for the studied
storage period (7 days).
3.3. Eﬀects on soluble sugars
Generally speaking, six soluble sugars were detected in the
studied samples, namely glucose, fructose, sucrose, lactose,
galactose and mannitol (Table 3). Mannitol was only detected
in the yogurts added with the A. bisporus extract, although it
co-eluted with galactose. The most abundant soluble sugar
was sucrose, followed by lactose. For the sample containing
phytosterols (YPhy), no fructose was detected and lower
amounts of sucrose and lactose were detected. For all sugars
but galactose, there was a significant interaction between ST
and IT. For this soluble sugar, all samples were significantly
diﬀerent. The highest amount was recorded in the yogurt with
the A. bisporus extract (YAb) and the lowest in the yogurt with
pure ergosterol at an amount mimicking the one present in
the A. bisporus extract (YPEAb). Overall, there was an increase
of lactose overtime, which can be explained by the combi-
nation of galactose with glucose, the monosaccharides of this
disaccharide. Through the EMM, it can be concluded that only
the control samples (FY – base yogurt with no additives)
Table 1 Ergosterol content in the samples after incorporation
Ergosterol content (g per 100 g)
ST 0 days 7 days
FY Nd Nd
YPhy Nd Nd
YAb 0.061 ± 0.01 0.062 ± 0.01
YPEAb 0.062 ± 0.01 0.063 ± 0.01
YPEPhy 1.952 ± 0.03 1.968 ± 0.02
Ergosterol content in the Agaricus bisporus extract: 36.72 ± 0.01 mg g−1
extract; nd – not detected.
Table 2 Nutritional proﬁle (g per 100 g) and energy values (kcal per 100 g) of the evaluated yogurt samples
Moisture Fat Protein Ash Total carbohydrates Energy
Storage time (ST) 0 days 81 ± 3 1.5 ± 0.4 4.1 ± 0.4 1.19 ± 0.04 12 ± 3 329 ± 41
7 days 81 ± 3 1.6 ± 0.5 3.9 ± 0.3 1.1 ± 0.1 12 ± 4 333 ± 45
p-Value (n = 30) Student T test 0.44 0.003 <0.001 <0.001 <0.001 <0.001
Incorporation type (IT) FY 80.0 ± 0.1 0.99 ± 0.02 3.75 ± 0.03 1.19 ± 0.03 14.0 ± 0.1 335 ± 2
YPhy 86.7 ± 3 2.3 ± 0.2 4.11 ± 0.05 1.1 ± 0.1 5.7 ± 0.3 251 ± 1
YPEAb 80.2 ± 0.7 1.41 ± 0.05 4.2 ± 0.6 1.13 ± 0.04 13.07 ± 0.9 342 ± 11
YPEPhy 79.3 ± 0.9 1.5 ± 0.2 3.6 ± 0.1 1.10 ± 0.06 14.4 ± 0.9 361 ± 17
YAb 78.7 ± 0.1 1.46 ± 0.06 4.2 ± 0.2 1.19 ± 0.05 14.4 ± 0.3 367 ± 4
p-Value (n = 12) Tukey’s HSD test <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
ST × IT (n = 60) p-Value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Results are expressed as mean ± amplitude (values obtained under diﬀerent conditions – variations of the non-fixed factor: ST or IT).
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showed a decrease in sucrose over time, while the commercial
samples incorporated with phytosterols (YPhy) maintained the
quantities, which were very low in comparison with the other
yogurt samples (ESI 1B†).
3.4. Eﬀects on fatty acids
The fatty acid profiles, analyzed through GC coupled with a
flame ionization detector and expressed in a relative percen-
tage, are present in Table 4.
Only the six most abundant fatty acids are represented in
the table, given their higher contribution to the nutritional
and organoleptic profiles. Of these, the most abundant were
oleic acid (C18:1) and palmitic acid (C16:0). Although yogurts
are considered healthy foodstuﬀs, the saturated fatty acid
(SFA) fraction was higher than the monounsaturated fraction,
which in turn is higher than the polyunsaturated one; still, the
most abundant individual fatty acid is oleic acid, which is
known for its beneficial properties for health.26,27 The sample
containing phytosterols showed a lower SFA content and a
higher level of oleic and linoleic acids (C18:2). For all fatty acids,
the interaction between ST and IT was significant. In fact very
few changes were expected given that the yogurts had conserva-
tives in their composition (E202, potassium sorbate), and were
only kept for 7 days under refrigeration, not allowing lipid per-
oxidation to excerpt great eﬀects, which could reveal the benefits
of the molecules included in the A. bisporus extract.
3.5. Eﬀects on antioxidant activity
The results of the antioxidant activity of A. bisporus and pure
ergosterol are presented in Table 5. The antioxidant activity of
the diﬀerent yogurts relying on the 2,2-diphenyl-1-picrylhydrazyl
(DPPH) radical scavenging activity is also represented in Table 5.
Both revealed antioxidant eﬀects (EC50 values of 3.99 ±
0.04 mg mL−1 and 0.46 ± 0.01 mg mL−1, respectively for
A. bisporus and pure ergosterol), the strong activity exhibited
by ergosterol being highlighted. There was a significant inter-
action between the ST and IT. The best yogurt in terms of anti-
oxidant activity was the one incorporated with pure ergosterol
at the same amount as the phytosterols (YPEPhy), whilst the
second one was the one incorporated with the A. bisporus
extract (YAb). Summarizing, YPEPhy showed the highest
activity needing 52 ± 9 mg mL−1 to exert 50% of activity,
followed by YAb (EC50 of 93 ± 3 mg mL
−1). Although YAb and
YPEAb have the same amount of ergosterol, YAb revealed a
higher antioxidant activity, which can be justified due to the
presence of other bioactive molecules in the extract able to
Table 4 Fatty acid composition (relative percentage) of the evaluated yogurt samples
C14:0 C16:0 C18:0 C18:1 C18:2 C18:3 SFA MUFA PUFA
Storage time (ST) 0 days 8 ± 4 24 ± 9 9 ± 4 28 ± 12 10 ± 6 2 ± 4 58 ± 23 30 ± 12 12 ± 10
7 days 9 ± 4 24 ± 9 9 ± 4 27 ± 13 10 ± 6 2 ± 4 58 ± 23 29 ± 13 13 ± 10
p-Value (n = 30) Student T test <0.001 <0.001 0.001 <0.001 <0.001 <0.001 0.006 <0.001 <0.001
Incorporation
type (IT)
FY 10.2 ± 0.1 28.9 ± 0.4 12.7 ± 0.1 20.8 ± 0.2 7.1 ± 0.2 0.35 ± 0.02 69.6 ± 0.3 22.9 ± 0.4 7.4 ± 0.2
YPhy 0.79 ± 0.1 6.27 ± 0.05 2.1 ± 0.1 52.8 ± 0.5 21.43 ± 0.06 11.30 ± 0.05 12.9 ± 0.4 54.3 ± 0.4 32.80 ± 0.05
YPEAb 10.68 ± 0.08 27.8 ± 0.3 10.9 ± 0.4 21.1 ± 0.6 7.0 ± 0.4 0.30 ± 0.08 69.2 ± 0.3 23.1 ± 0.6 7.3 ± 0.5
YPEPhy 10.8 ± 0.7 28.8 ± 0.6 11.0 ± 0.4 21.4 ± 0.6 7.53 ± 0.07 0.31 ± 0.03 68.7 ± 0.5 23.4 ± 0.6 7.8 ± 0.1
YAb 10.8 ± 0.5 28.3 ± 0.4 10.4 ± 0.3 21.2 ± 0.5 7.2 ± 0.4 0.38 ± 0.03 68.5 ± 0.8 23.2 ± 0.4 7.6 ± 0.4
p-Value (n = 12) Tukey’s HSD
test
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
ST × AD (n = 60) p-Value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
The results are expressed as mean ± amplitude (values obtained under diﬀerent conditions – variations of the non-fixed factor: ST or IT). Myristic
acid (C14:0); palmitic acid (C16:0); stearic acid (C18:0); oleic acid (C18:1n9); linoleic acid (C18:2n6c); α-linolenic acid (C18:3n3). The diﬀerence to
100% corresponds to other 11 less abundant fatty acids in the case of FY, YAb, YPEAb and YPEPhy samples and to other 15 less abundant fatty
acids in the case of the YPhy sample (data not shown).
Table 3 Soluble sugar (g per 100 g−1) composition of the evaluated yogurt samples
Fructose Glucose Sucrose Lactose Galactose Total sugars
Storage time (ST) 0 days 0.3 ± 0.1 0.97 ± 0.06 4 ± 2 2 ± 1 0.6 ± 0.4 8 ± 3
7 days 0.15 ± 0.09 0.98 ± 0.07 5 ± 3 3 ± 2 0.5 ± 0.4 10 ± 4
p-Value (n = 30) Student T test <0.001 0.241 <0.001 <0.001 0.03 <0.001
Incorporation type (IT) FY 0.31 ± 0.02 1.00 ± 0.01 4.5 ± 0.3 3.5 ± 0.6 0.23 ± 0.06b 9.5 ± 0.2
YPhy — 0.90 ± 0.02 0.031 ± 0.002 0.099 ± 0.002 1.02 ± 0.02d 2.05 ± 0.05
YPEAb 0.2 ± 0.1 0.97 ± 0.05 6 ± 1 3.8 ± 0.8 0.15 ± 0.04a, b 11 ± 2
YPEPhy 0.25 ± 0.09 1.00 ± 0.08 6 ± 1 3.7 ± 0.7 0.24 ± 0.02c, b 11 ± 2
YAb 0.24 ± 0.07 1.02 ± 0.05 6.0 ± 0.6 3.8 ± 0.6 a1.1 ± 0.3e 12 ± 1
p-Value (n = 12) Tukey’s HSD test <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
ST × IT (n = 60) p-Value <0.001 <0.001 <0.001 <0.001 0.346 <0.001
Results are expressed as mean ± amplitude (values obtained under diﬀerent conditions – variations of the non-fixed factor: ST or IT). aGalactose
+ mannitol.
Food & Function Paper
This journal is © The Royal Society of Chemistry 2017 Food Funct., 2017, 8, 103–110 | 107
Pu
bl
ish
ed
 o
n 
13
 D
ec
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
8/
04
/2
01
8 
14
:0
1:
03
. 
View Article Online
influence the antioxidant activity. The sample providing the
weakest activity was, as expected, FY (base yogurt with no addi-
tives) (EC50 = 324 ± 17 mg mL
−1). Through the EMM analysis it
was noticed that all samples, except the control yogurts,
increased their antioxidant activity (EC50 values became lower)
(ESI 1C†). This can be justified taking into account the pres-
ence of some resilient antioxidant compounds that withstand
the storage time and display their activity only after a certain
period of time, or by synergies among compounds. The main-
tenance of nutritional and organoleptic properties of foodstuﬀ
is a quite interesting result, given that these compounds oﬀer
the possibility to halt protein degradation, while conferring
bioactive properties, even after 7 days of storage time. As men-
tioned above the ergosterol levels were maintained during this
period, and the antioxidant activity increased, a fact that can
be associated with ergosterol presence in the yogurts.
3.6. Eﬀects on cytotoxic properties
A. bisporus and pure ergosterol results regarding the cytotoxic
properties are described in Table 6. As can be seen, both
A. bisporus and pure ergosterol exhibited cytotoxic eﬀects
against all the tested tumor cell lines. Furthermore, A. bisporus
did not show any toxicity against the normal cells PLP2 at the
maximum tested concentration. Pure ergosterol revealed toxi-
city at a concentration of 89.54 ± 3.29 μg mL−1, which is much
higher than the one needed to exert 50% of activity in tumor
cells, and more importantly, much higher than the toxic con-
centration of the ellipticine. Table 6 also displays the cytotoxic
properties of the yogurts incorporating pure ergosterol and the
mushroom extract, against various human tumor cell lines
(MCF-7 – breast carcinoma, NCI-H460 non-small lung carci-
noma, HeLa – cervical carcinoma, HepG2 – liver carcinoma)
and a non-tumor cell line from a porcine liver. This activity is
generally carried out against specific individual anticancer
molecules such as ellipticine (used here as the positive
control) whose concentration at which 50% of the cell growth
is inhibited (GI50 values), is also registered in Table 6.
Although no strong in vitro antitumor activity was expected
from the samples, the objective of this assay was to determine
potential chemopreventive eﬀects of the yogurts. The achieved
results pointed out the existence of a significant interaction
for all tumor cell lines. The yogurt added with pure ergosterol
at the same amount as the phytosterols used in commercial
yogurts (YPEPhy), showed the best results. In terms of toxicity
for normal cells, only this yogurt showed toxic eﬀects at a con-
centration of approximately 189 ± 8 µg mL−1. Nevertheless,
this concentration is much higher than the concentration
needed to exert 50% of activity against tumor cell lines. None
of the other yogurts showed toxicity against PLP2 up to the
maximum tested concentration (400 µg mL−1). Thus, the toxi-
city observed for the non-tumor cells may be related to the
used high ergosterol concentration (2 g per 100 g yogurt).
When the ergosterol concentration is lower, as is the case of
Table 5 DPPH radical scavenging activity of the evaluated yogurt
samples
EC50 values (mg mL
−1)
Storage time (ST) 0 days 152 ± 87
7 days 143 ± 104
p-Value (n = 30) Tukey’s HSD test <0.001
Incorporation type (IT) FY 324 ± 17
YPhy 141 ± 9
YPEAb 126 ± 16
YPEPhy 52 ± 9
YAb 93 ± 3
p-Value (n = 12) Tukey’s HSD test <0.001
ST × IT (n = 60) p-Value <0.001
A. bisporus mycosterol extract 3.99 ± 0.04
Pure ergosterol 0.46 ± 0.01
Trolox (positive control) 0.041 ± 0.001
The results for yogurt samples are expressed as mean ± amplitude
(values obtained under diﬀerent conditions – variations of the non-
fixed factor: ST or IT); the results for the mycosterol extract, pure
ergosterol and trolox are expressed as mean ± standard deviation.
Table 6 Cytotoxic properties of the studied yogurt samples (GI50 values, µg mL
−1)
MCF-7 NCI-H460 HeLa HepG2 PLP2
Storage time (ST) 0 days 227 ± 137 191 ± 110 190 ± 125 219 ± 131 332 ± 99
7 days 171 ± 111 147 ± 90 143 ± 90 193 ± 120 327 ± 106
p-Value (n = 18) Student T test <0.001 <0.001 <0.001 <0.001 <0.001
Incorporation type (IT) YPEAb 265 ± 27 219 ± 38 217 ± 18 247 ± 22 400
YPEPhy 31 ± 12 33 ± 7 23 ± 3 41 ± 4 189 ± 8
YAb 301 ± 49 253 ± 25 261 ± 53 329 ± 15 400
p-Value (n = 12) Tukey’s HSD test <0.001 <0.001 <0.001 <0.001 <0.001
ST × IT (n = 18) p-Value <0.001 <0.001 <0.001 <0.001 <0.0001
MCF-7 NCI-H460 HeLa HepG2 PLP2
FY >400 >400 >400 >400 >400
YPhy >400 >400 >400 >400 >400
A. bisporus mycosterol extract 84 ± 5 123 ± 9 97.0 ± 0.4 95 ± 2 >400
Pure ergosterol 30 ± 2 49 ± 4 38 ± 2 34 ± 3 89.54 ± 3.29
Ellipticine (positive control) 0.91 ± 0.04 0.91 ± 0.11 1.14 ± 0.21 3.22 ± 0.67 3.2 ± 0.7
The results for yogurt samples are expressed as mean ± amplitude (values obtained under diﬀerent conditions – variations of the non-fixed
factor: ST or IT); the results for the mycosterol extract, pure ergosterol and ellipticine are expressed as mean ± standard deviation.
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YAb and YPEPhy (0.075 g ergosterol per 100 g yogurt), no
hepatotoxicity was registered. Thus, the choice of concen-
trations close to this late value can provide toxicity to tumor
cells but not normal liver cells.
4. Conclusion
Bio-residues from A. bisporus, the most consumed mushroom
worldwide, were used as a source of mycosterols to be tested in
comparison to the already commercially available yogurts con-
taining phytosterols. They can be obtained from less noble
biomass provided by mushroom cultivation and processing
industries, returning added value products, in-line with the
circular bioeconomy concept. The used extraction procedure is
simple to apply, low-cost and avoids purification steps, providing
functional ingredients suitable for food and/or beverage appli-
cations, with the advantage of imparting hypocholesterolemic
eﬀects as demonstrated by Gil-Ramírez et al.19 From the
obtained results, the A. bisporus extract seemed to preserve
yogurt’s protein and lipid fractions, probably due to its anti-
oxidant potential. Furthermore, sucrose degradation over time
also decreased and a lower toxic eﬀect against normal cells was
observed in comparison with pure ergosterol (although none of
them is toxic). The yogurts incorporated with 2 g of the
A. bisporus extract (YAb) showed a stronger bioactivity than the
samples incorporated with phytosterols, meaning that this
extract presents high potential for application in the food indus-
try. In terms of the present proposal of using mycosterols, their
eﬃcacy was found very similar to phytosterols, highlighting their
viable use, and benefits associated with mushroom-derived
sterols, their price and availability. The fact that this extract is a
mixture of molecules was found interesting since the developed
synergies evidenced beneficial eﬀects over the ascribed bioacti-
vities. This topic is worth further investigation to uncover the
potentialities of this mushroom for food applications.
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